IMUX - IMMUNIC, INC.
10.75
0.770 7.163%
Share volume: 375,270
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$9.98
0.77
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | 05-15-2025 | 08-07-2025 | 11-13-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 104.155 M | 86.491 M | 64.762 M | 20.515 M | 61.429 M | 40.704 M | 24.052 M | |
| Current Assets | 102.615 M | 84.978 M | 63.266 M | 18.975 M | 59.842 M | 39.273 M | 22.869 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 97.312 M | 79.698 M | 59.071 M | 14.304 M | 55.310 M | 35.132 M | 15.483 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 442.000 K | 585.000 K | 618.000 K | 572.000 K | 612.000 K | 640.000 K | 608.000 K | |
| Other Assets | 1.098 M | 928.000 K | 878.000 K | 968.000 K | 975.000 K | 791.000 K | 575.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 104.155 M | 86.491 M | 64.762 M | 20.515 M | 61.429 M | 40.704 M | 24.052 M | |
| Total liabilities | 20.579 M | 22.918 M | 23.543 M | 25.802 M | 27.518 M | 30.205 M | 30.725 M | |
| Total current liabilities | 20.146 M | 22.677 M | 23.357 M | 25.592 M | 27.313 M | 30.079 M | 30.618 M | |
| Accounts Payable | 6.767 M | 7.894 M | 6.042 M | 6.011 M | 7.893 M | 7.918 M | 10.138 M | |
| Other liabilities | 433.000 K | 241.000 K | 186.000 K | 210.000 K | 205.000 K | 126.000 K | 107.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 433.000 K | 241.000 K | 186.000 K | 210.000 K | 205.000 K | 126.000 K | 107.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 83.576 M | 63.573 M | 41.219 M | -5.287 M | 33.911 M | 10.499 M | -6.673 M | |
| Common stock | 519.765 M | 521.647 M | 523.557 M | 527.661 M | 595.078 M | 597.188 M | 599.250 M | |
| Retained earnings | -440.476 M | -461.856 M | -486.224 M | -536.872 M | -563.692 M | -589.271 M | -608.571 M |